• Xylem Inc. recently announced a landmark agreement with Dow Inc. to design, build and operate an advanced, site-wide water treatment and reuse system at Dow’s large industrial complex in Fort Saskatchewan, Alberta, with operations targeted to begin by August 2028.
• The deal makes Xylem responsible for the full water cycle, from raw water treatment to converting processed water into reusable supply, showcasing how integrated reuse can cut freshwater demand and support more resilient industrial operations and local resources.
• We’ll now examine how this end-to-end industrial water management agreement with Dow shapes Xylem’s investment narrative and long-term positioning.

The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

What Is Xylem's Investment Narrative?

To own Xylem, you need to believe in water as critical infrastructure and in the company’s ability to turn that necessity into steady, high quality earnings, supported by disciplined capital returns and acquisitions like Evoqua. The Dow agreement adds a real-world proof point to Xylem’s push into end-to-end, service-heavy industrial water solutions, but given the long build-out to 2028, it is more of a long-term positioning win than a near-term earnings catalyst. Near term, the key drivers still look like execution against modest revenue guidance, integration of acquired businesses and how effectively management deploys the new US$1.50 billion buyback alongside a growing dividend. The risk is that Xylem’s slower forecast growth and low return on equity limit investor patience if large, complex projects underperform or slip.

However, investors should also be aware of how Xylem’s low forecast return on equity could cap upside. Xylem's shares have been on the rise but are still potentially undervalued by 14%. Find out what it's worth.

Exploring Other Perspectives

Four Simply Wall St Community valuations cluster between about US$123.56 and US$150.65, highlighting wide opinions on Xylem’s worth. Set that against Xylem’s slower forecast growth and execution risk on large projects like Dow, and you can see why different investors may reach very different conclusions about its longer term performance.

Explore 4 other fair value estimates on Xylem - why the stock might be worth just $123.56!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Xylem research is our analysis highlighting 6 key rewards that could impact your investment decision.
• Our free Xylem research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Xylem's overall financial health at a glance.

Searching For A Fresh Perspective?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Uncover the next big thing with 23 elite penny stocks that balance risk and reward.
• Find 47 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.